Daryl Nelson
Researchers Create Chip To Dectect Prostate Cancer in Urine
Scientists from the University of Parma in Italy have developed a chip that would be able to detect a suspected marker of aggressive prostate cancer in urine, which could make cancer testing easier and less invasive.
Robotic Surgery Most Common Prostate Cancer Treatment in US
Robot-assisted radical prostatectomies have grown to become the most common type of surgical treatment for prostate cancer in the United States.
Men Responsible for Half of Infertility Cases Among Couples
Many couples struggle with fertility – about 15 percent of couples in United States. Though infertility is often thought of as a woman’s issue, data suggests half of couples are affected by male infertility.
Study: Exercise Improves Survival Rate of Prostate Patients
Regular exercise doesn’t just do wonders for the heart and figure. New research suggests physical activity may be beneficial for those with low-grade prostate cancer.
Study: Prostate Blood Test Reduces Cancer Deaths
A new study suggests men screened for cancer using the prostate specific antigen (PSA) blood test reduces the number of prostate cancer deaths.
Western States Boast the Best Wellbeing, Southern States the Worst
Want to be happier? Move out west.
The latest Gallup report finds people living in western states have the highest well-being.
Researchers Find an Overuse of Prostate Cancer Treatment in older Men
Treatment isn’t always needed for older male patients with prostate cancer and a short life expectancy, according to researchers at the Yale School of Medicine.
Prostate, Colon, Lung Cancer Rates Down
Cancer rates for lung, prostate and colon cancer has dropped significantly for men in the United States, according to the latest Cancer Facts & Figures report from the American Cancer Society.
High-Grade Prostate Cancer Linked to Metabolic Syndrome
Metabolic syndrome does not raise a mans risk of developing prostate cancer overall, but does raise their risk of aggressive prostate cancer, according to a report presented at the 27th Annual Congress of the European Association of Urology.
New Prostate Cancer Med Extends Life by Nearly Five Months: Study
A study, conducted by pharmaceutical company Astellas Pharma Europe LTD, found when compared to patients prescribed a placebo, an investigational drug extended life by almost five months in men with advanced prostate cancer who already underwent chemotherapy treatment.